Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients.
Li H, Hu H, Wang R, Pan Y, Wang L, Li Y, Zhang Y, Ye T, Zhang Y, Li B, Shen L, Sun Y, Chen H.
Li H, et al. Among authors: wang l, wang r.
Onco Targets Ther. 2014 Apr 3;7:513-24. doi: 10.2147/OTT.S60122. eCollection 2014.
Onco Targets Ther. 2014.
PMID: 24729716
Free PMC article.